Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

Clinical trial NCT00861380 · COMPLETED

Trial details

NCT number: NCT00861380
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Streptococcal Streptococcus Pneumoniae

Start date: 2009-05-04
Primary completion: 2012-01-31
Enrollment: 41188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.